Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
March 27, 2013
Mammalian expression systems and transfection techniques
Daunia Laurenti, Lezanne Ooi
Cells
|
October 17, 2020
Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington's Disease
Emanuela Paldino, Vincenza D'Angelo, Daunia Laurenti, et al.
Frontiers in Pharmacology
|
April 22, 2022
Polysaccharide Peptide Extract From <i>Coriolus versicolor</i> Increased T<sub>max</sub> of Tamoxifen and Maintained Biochemical Serum Parameters, With No Change in the Metabolism of Tamoxifen in the Rat
Valentina Razmovski-Naumovski, Benjamin Kimble, Daunia Laurenti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 9, 2013
Generation of hydrogen peroxide-resistant murine neuroblastoma cells: a target discovery platform for novel neuroprotective genes
Annette E Maczurek, Rebekka Wild, Daunia Laurenti, et al.
Plos One
|
October 27, 2010
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease
Carmela Giampà, Daunia Laurenti, Serenella Anzilotti, et al.
Brain Research Bulletin
|
January 29, 2011
Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease
Serenella Anzilotti, Carmela Giampà, Daunia Laurenti, et al.
Neurobiology of Disease
|
March 14, 2009
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
Carmela Giampà, Stefano Patassini, Antonella Borreca, et al.
The European Journal of Neuroscience
|
March 18, 2009
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease
Carmela Giampà, Silvia Middei, Stefano Patassini, et al.
Neurobiology of Disease
|
December 11, 2012
Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
Alessandro Leuti, Daunia Laurenti, Carmela Giampà, et al.
Journal of Child Neurology
|
March 9, 2010
A case of PANDAS treated with tetrabenazine and tonsillectomy
Francesca Romana Fusco, Alessandra Pompa, Giorgio Bernardi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
March 27, 2013
Mammalian expression systems and transfection techniques
Daunia Laurenti, Lezanne Ooi
Cells
|
October 17, 2020
Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington's Disease
Emanuela Paldino, Vincenza D'Angelo, Daunia Laurenti, et al.
Frontiers in Pharmacology
|
April 22, 2022
Polysaccharide Peptide Extract From <i>Coriolus versicolor</i> Increased T<sub>max</sub> of Tamoxifen and Maintained Biochemical Serum Parameters, With No Change in the Metabolism of Tamoxifen in the Rat
Valentina Razmovski-Naumovski, Benjamin Kimble, Daunia Laurenti, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 9, 2013
Generation of hydrogen peroxide-resistant murine neuroblastoma cells: a target discovery platform for novel neuroprotective genes
Annette E Maczurek, Rebekka Wild, Daunia Laurenti, et al.
Plos One
|
October 27, 2010
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease
Carmela Giampà, Daunia Laurenti, Serenella Anzilotti, et al.
Brain Research Bulletin
|
January 29, 2011
Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease
Serenella Anzilotti, Carmela Giampà, Daunia Laurenti, et al.
Neurobiology of Disease
|
March 14, 2009
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
Carmela Giampà, Stefano Patassini, Antonella Borreca, et al.
The European Journal of Neuroscience
|
March 18, 2009
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease
Carmela Giampà, Silvia Middei, Stefano Patassini, et al.
Neurobiology of Disease
|
December 11, 2012
Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
Alessandro Leuti, Daunia Laurenti, Carmela Giampà, et al.
Journal of Child Neurology
|
March 9, 2010
A case of PANDAS treated with tetrabenazine and tonsillectomy
Francesca Romana Fusco, Alessandra Pompa, Giorgio Bernardi, et al.
Page
of 2